Established bioprocesses for producing antibodies as a basis for future planning.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Advances in Biochemical Engineering/Biotechnology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/10_014PMID 16989256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EXPRESSION OF RECOMBINANT PROTEINS IN THE MILK OF TRANSGENIC ANIMALS

  2007cited by this paper
• Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system

  2006cited by this paper
• Gene Expression Systems: Using Nature For The Art Of Expression

  2006cited by this paper
• Transgenic animal bioreactors

  2004cited by this paper
• Molecular farming of pharmaceutical proteins

  2004cited by this paper
• Antibodies and Genetically Engineered Related Molecules: Production and Purification

  2004cited by this paper
• Human therapeutic proteins from silkworms

  2003cited by this paper
• Transgenic silkworms produce recombinant human type III procollagen in cocoons

  2003cited by this paper
• Therapeutic antibodies for human diseases at the dawn of the twenty-first century

  2003cited by this paper
• Engineered antibodies

  2003cited by this paper
• Plantibodies: applications, advantages and bottlenecks.

  2002cited by this paper
• Hybridoma, Antibody Production

  2002cited by this paper
• Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand: comparison with protein A and protein G.

  2002cited by this paper
• Uncorking the biomanufacturing bottleneck

  2002cited by this paper
• Antibody manufacture in transgenic animals and comparisons with other systems

  2002cited by this paper
• Monoclonal antibodies: boundless potential, daunting challenges

  2002cited by this paper
• Monoclonal antibody manufacturing in transgenic plants--myths and realities.

  2002cited by this paper
• Production of secretory IgA antibodies in plants.

  2001cited by this paper
• Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.

  2001cited by this paper
• Production of an anti-prostate-specific antigen single-chain antibody fragment from Pichia pastoris.

  2001cited by this paper
• Expression of single-chain Fv-Fc fusions in Pichia pastoris.

  2001cited by this paper
• The regulation of biologic products derived from bioengineered plants.

  2001cited by this paper
• Novel ligands for the affinity-chromatographic purification of antibodies.

  2001cited by this paper
• Therapeutic antibody expression technology.

  2001cited by this paper
• Perfusion Cell Culture in Disposable Bioreactors

  2001cited by this paper
• Biopharma: Biopharmaceutical Products in the U.S. Market

  2001cited by this paper
• Foreign protein production in plant tissue cultures.

  2000cited by this paper
• Affinity chromatography on immobilized "biomimetic" ligands. Synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand.

  2000cited by this paper
• SMB EMERGES AS CHIRAL TECHNIQUE: Pharmaceutical chemical makers see method as new route to enantiomers

  2000cited by this paper
• Transgenic plants as factories for biopharmaceuticals

  2000cited by this paper
• Affinity purification of immunoglobulins from chicken egg yolk using a new synthetic ligand.

  2000cited by this paper
• Transgenic milk as a method for the production of recombinant antibodies

  1999cited by this paper
• Production of Monoclonal Antibodies

  1999cited by this paper
• Encyclopedia of bioprocess technology : fermentation, biocatalysis, and bioseparation

  1999cited by this paper
• Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing.

  1999cited by this paper
• Therapeutic antibody fragments with prolonged in vivo half-lives

  1999cited by this paper
• Expanded bed protein A affinity chromatography of a recombinant humanized monoclonal antibody: process development, operation, and comparison with a packed bed method.

  1999cited by this paper
• Applications And Engineering Of Monoclonal Antibodies

  1998cited by this paper
• Design, synthesis, and application of a Protein A mimetic

  1998cited by this paper
• F(ab')2 molecules made from Escherichia coli produced Fab' with hinge sequences conferring increased serum survival in an animal model.

  1998cited by this paper
• Biopharmaceuticals: Biochemistry and Biotechnology

  1998cited by this paper
• Handbook of Process Chromatography: A Guide to Optimization, Scale Up, and Validation

  1997cited by this paper
• Molecular farming in plants: Oilseeds as vehicles for the production of pharmaceutical proteins

  1997cited by this paper
• FDA approves new kind of lymphoma treatment. Food and Drug Administration.

  1997cited by this paper
• Practical Considerations in Operation and Scale‐up of Spin‐Filter Based Bioreactors for Monoclonal Antibody Production

  1996cited by this paper
• Production of Antibody Fragments in Escherichia coli

  1996cited by this paper
• Protein a mimetic peptide ligand for affinity purification of antibodies

  1996cited by this paper
• In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production

  1995cited by this paper
• Monoclonal antibodies : principles and applications

  1995cited by this paper
• Buffer exchange using size exclusion chromatography, countercurrent dialysis, and tangential flow filtration: Models, development, and industrial application

  1995cited by this paper
• Large-scale manufacture of monoclonal antibodies for use in humans.

  1990cited by this paper
• Reshaping human antibodies for therapy

  1988cited by this paper
• Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

  1984cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper

• Preparation and application of a beta-d-glucan microsphere conjugated protein A/G.

  2020cites this paper
• Tackling Cancer with Yeast-Based Technologies.

  2019cites this paper
• Posttranslational Modifications in Algae: Role in Stress Response and Biopharmaceutical Production

  2019cites this paper
• Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: a Review

  2019cites this paper
• Microbioreactors and Perfusion Bioreactors for Microbial and Mammalian Cell Culture

  2019cites this paper
• Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation

  2018cites this paper
• Biochemical and metabolic engineering approaches to enhance production of therapeutic proteins in animal cell cultures

  2018cites this paper
• Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture

  2017cites this paper
• Bioreactor productivity and media cost comparison for different intensified cell culture processes

  2017cites this paper
• Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non-Protein-A Chromatographic Platform Based on Process Economics.

  2017cites this paper
• Efficient antibody production in the methylotrophic yeast Ogataea minuta by overexpression of chaperones.

  2017cites this paper
• Algae-Made Antibodies and Immunotoxins

  2016cites this paper
• Stem cell value chains

  2016cites this paper
• Process development of lentiviral vector expression, purification and formulation for gene therapy applications

  2016cites this paper
• Algae-Based Biopharmaceuticals

  2016cites this paper
• Purification of monoclonal antibodies by chemical affinity mixed mode chromatography

  2015cites this paper
• Partitioning in aqueous two‐phase systems: Analysis of strengths, weaknesses, opportunities and threats

  2015cites this paper
• Crystal Ball Planning for Analytics Implementation in Singapore

  2014cites this paper
• Application of peptide chromatography for the isolation of antibodies from bovine skim milk, acid whey and colostrum

  2014cites this paper
• Evaluating the potential of continuous processes for monoclonal antibodies : economic, environmental and operational feasibility

  2014influential citation
• Application of 4'-terpyridinylsulfanylethylamine resins for the purification of monoclonal antibodies by mixed-mode chromatography.

  2014cites this paper
• Evaluating the economic and operational feasibility of continuous processes for monoclonal antibodies

  2014cites this paper
• A novel microscale crossflow device for the rapid evaluation of microfiltration processes

  2014cites this paper
• Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty

  2013cites this paper
• Bioreactors: A Rapid Approach for Secondary Metabolite Production

  2013cites this paper
• Microscale methods to establish scalable operations for protein impurity removal prior to packed bed steps

  2013influential citation
• Bright Future Outlook and Huge Challenges to Overcome: An Attempt to Write the Short Story of the Biopharma Industry with Current Status, Selected Issues, and Potential Solutions in Discovery, R&D, and Manufacturing

  2013cites this paper
• Feedback-mediated Regulation of Human Hematopoietic Stem Cell Fate

  2013cites this paper
• Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion Technologies

  2013cites this paper
• MALDI-ToF mass spectrometry biomarker profiling via multivariate data analysis application in the biopharmaceutical bioprocessing industry

  2013cites this paper
• High-level secretory expression, purification, and characterization of an anti-human Her II monoclonal antibody, trastuzumab, in the methylotrophic yeast Pichia pastoris

  2013cites this paper
• Rapid, Large-Scale Production of Full-Length, Human-Like Monoclonal Antibodies

  2012cites this paper
• Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling.

  2012cites this paper
• An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency

  2012cites this paper
• Engineering aggregation resistance in IgG by two independent mechanisms: lessons from comparison of Pichia pastoris and mammalian cell expression.

  2012cites this paper
• Economic comparison of diagnostic antibody production in perfusion stirred tank and in hollow fiber bioreactor processes

  2011cites this paper
• Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

  2011cites this paper
• Bioreactor Systems for Producing Antibody from Mammalian Cells

  2011cites this paper
• Antibody Expression from Bacteria to Transgenic Animals

  2011cites this paper
• Microscale bioprocessing platform for the evaluation ofmembrane filtration processes for primary recovery

  2011cites this paper
• Antibody expression and production

  2011cites this paper
• Toward Greener Therapeutic Proteins

  2011cites this paper
• Protein Expression in Nonconventional Yeasts

  2010cites this paper
• Environmental considerations in biologics manufacturing

  2010cites this paper
• Bioreactors, Cell Culture, Commercial Production

  2010cites this paper
• focusing on the design and optimization of a large scale biopharmaceutical facility using process simulation and scheduling tools . Design and Optimization of a Large Scale Biopharmaceutical Facility Using Process Simulation and Scheduling Tools by

  2010cites this paper
• Antibody expression kinetics in glycoengineered Pichia pastoris

  2010cites this paper
• Chapter 4. Antibody Glycosylation

  2009cites this paper
• Production of monoclonal antibodies by glycoengineered Pichia pastoris.

  2009cites this paper
• Improving bioreactor cultivation conditions for sensitive cell lines by dynamic membrane aeration

  2009cites this paper
• Production of recombinant proteins and monoclonal antibodies - Techno-enonomical evaluation of the production methods

  2009influential citation
• The art of antibody process development.

  2008cites this paper
• Process Economic Drivers in Industrial Monoclonal Antibody Manufacture

  2008cites this paper
• ENHANCED PRODUCTION CONSIDERING TEMPERATURE EFFECTS ON NEW HYBRIDOMAS FOR BOVINE NATURAL KILLER CELL MONOCLONAL ANTIBODIES

  2008cites this paper
• The Development of Antibody Purification Technologies

  2008cites this paper
• Purification of a human immunoglobulin G1 monoclonal antibody from transgenic tobacco using membrane chromatographic processes.

  2008cites this paper
• Purification of monoclonal antibody from tobacco extract using membrane-based bioseparation techniques

  2008cites this paper
• Transcriptome and proteome analysis of antibody‐producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture

  2008cites this paper
• Potential applications of designed ankyrin repeat proteins in diagnostics and therapeutics.

  2007cites this paper
• Evaluation of a novel agarose-based synthetic ligand adsorbent for the recovery of antibodies from ovine serum.

  2007cites this paper
• A Microstructure Heat Exchanger for Quenching the Metabolism of Mammalian Cells

  2007cites this paper
• Process economics of industrial monoclonal antibody manufacture.

  2007cites this paper
• ENHANCING THE LONGEVITY OF ION-SELECTIVE ELECTRODE ARRAYS IN BIOREACTORS

  2007cites this paper
• C‐Terminal antibodies (CTAbs): A simple and broadly applicable approach for the rapid generation of protein‐specific antibodies with predefined specificity

  2007cites this paper
• Anticorps monoclonaux et recombinants, 30 ans déjà...

  2006cites this paper